Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.

@article{Rauck2012EfficacyAS,
  title={Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.},
  author={Richard L. Rauck and Lowell W. Reynolds and Jonathan Geach and Janet K. Bull and Lisa M. Stearns and Morris Scherlis and Neha Jagdish Parikh and Larry Dillaha},
  journal={Current medical research and opinion},
  year={2012},
  volume={28 5},
  pages={
          859-70
        }
}
BACKGROUND AND OBJECTIVES A number of transmucosal fentanyl formulations have been developed for the management of breakthrough cancer pain (BTCP). Sublingual delivery of fentanyl, formulated as fentanyl sublingual spray, offers the potential for more rapid and greater absorption of fentanyl and associated onset of analgesic effect compared with other formulations. The objective of this study was to assess the efficacy and safety of fentanyl sublingual spray for the treatment of BTCP… CONTINUE READING
BETA

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Similar Papers

Loading similar papers…